Skip to main content

Advertisement

SpringerLink
Log in

Quality of life in female patients with acromegaly

  • Original Article
  • Published:
Journal of Endocrinological Investigation Aims and scope Submit manuscript

Abstract

Aim: The aim of the study was to assess the quality of life and depression status in female patients with acromegaly. Patients and methods: Fifty-seven female patients with acromegaly (21 inactive, 36 active) who were being followed-up at the Cerrahpasa Medical School, Endocrinology and Metabolism out-patient clinic, were included in the study. Depression status and quality of life of the patients were evaluated according to disease activity using the Beck Depression Inventory (BDI) and the Acromegaly Quality of Life (AcroQoL) Questionnaire. Prolactin, luteinizing hormone (LH), follicle-stimulating hormone (FSH), estradiol (E2), total and free testosterone, dehydroepiandrosterone sulfate (DHEA-SO4), 17α-hydroxyprogesterone, androstenedione, free thyroxin (FT4), thyrotropin (TSH), cortisol, GH and IGF-I were studied in the groups. Results: The AcroQoL total score in female patients with controlled acromegaly and uncontrolled acromegaly were 45.5 [Interquartile range (IQR)= 32.9−57.4], 47.7 [(IQR)= 38.6−63.3], respectively (p=0.53). There was no difference in BDI scores in acromegalic patients according to disease activity (p=0.41). In the correlation analysis, a strong negative correlation was found between AcroQoL total score and BDI score (r=−0.72, p<0.0001), OSAS (r=−0.32, p=0.01). Conclusion: This study showed that QoL was impaired in female patients with acromegaly even if they were in remission. Depressive mood and obstuctive sleep apnea syndrome (OSAS) could affect QoL in female patients with acromegaly.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Subscribe and save

Springer+ Basic
$34.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Arosio M, Reimondo G, Malchiodi E, et al. Predictors of morbidity and mortality in acromegaly: an Italian survey. Eur J Endocrinol 2012, 167: 189–98.

    CAS  PubMed  Google Scholar 

  2. Chanson P, Salenave S, Kamenicky P, Cazabat L, Young J. Acromegaly. Best Pract Res Clin Endocrinol Metab 2009, 23: 555–74.

    Article  CAS  PubMed  Google Scholar 

  3. Colao A, Ferone D, Marzullo P, Lombardi G. Systemic complications of acromegaly: Epidemiology, pathogenesis, and management. Endocr Rev 2004, 25: 102–50.

    Article  CAS  PubMed  Google Scholar 

  4. Webb SM. Quality of life in acromegaly. Neuroendocrinology 2006, 83: 224–9.

    Article  CAS  PubMed  Google Scholar 

  5. Webb SM, Prieto L, Badia X, et al. Acromegaly Quality of Life Questionnaire (AcroQoL), a new health related quality of life questionnaire for patients with acromegaly: development and psychometric properties. Clin Endocrinol 2002, 57: 251–8.

    Article  CAS  Google Scholar 

  6. Webb SM, Badia X, Surinach NL, for the Spanish AcroQoL Study Group. Validity and clinical applicability of the acromegaly quality of life questionnaire, AcroQoL: a 6-month prospective study. Eur J Endocrinol 2006, 155: 269–77.

    Article  CAS  PubMed  Google Scholar 

  7. Beck AT, Ward Ch, Mendelson M, Mosk J, Erbaugh J. An inventory for measuring depression. Arch Gen Psychiatry 1961, 4: 561–71.

    Article  CAS  PubMed  Google Scholar 

  8. Deyneli O, Yavuz D, Gozu H, et al. Evaluation of quality of life in Turkish patients with acromegaly. Proceedings 85th Annual Meeting Endocrine Society, Phidelphia, 2003, 3–508 (abstract).

  9. Giustina A, Chanson P, Bronstein MD, et al. A consensus on criteria for cure of acromegaly. J Clin Endocrinol Metab 2010, 95: 3141–8.

    Article  CAS  PubMed  Google Scholar 

  10. Biermasz NR, van Thiel SW, Pereira M, et al. Decreased quality of life in patients with acromegaly despite long term cure of growth hormone excess. J Clin Endocrinol Metab 2004, 89: 5369–76.

    Article  CAS  PubMed  Google Scholar 

  11. Trepp R, Everts R, Stettler C, et al. Assessment of quality of life in patients with uncontrolled vs controlled acromegaly using the Acromegaly Quality of Life Questionnaire (AcroQoL). Clin Endocrinol (Oxf) 2005, 63: 103–10.

    Article  Google Scholar 

  12. Rowles SV, Badia XP, Shalet SM, Webb SM, Trainer PJ. Quality of life (QoL) in patients with acromegaly is severely impaired: use of a novel measure of QoL: Acromegaly Quality of Life Questionnaire. J Clin Endocrinol Metab 2005, 90: 3337–41.

    Article  CAS  PubMed  Google Scholar 

  13. Psaras T, Honegger J, Gallwitz B, Milian M. Are there gender-specific differences concerning quality of life in treated acromegalic patients? Exp Clin Endocrinol Diabetes 2011, 119: 300–5.

    Article  CAS  PubMed  Google Scholar 

  14. Hua SC, Yan YH, Chang TC. Associations of remission status and lanreotide treatment with quality of life in patients with treated acromegaly. Eur J Endocrinol 2006, 155: 831–7.

    Article  CAS  PubMed  Google Scholar 

  15. Paisley AN, Rowles SV, Roberts ME, et al. Treatment of acromegaly improves quality of life, measured by AcroQol. Clin Endocrinol (Oxf) 2007, 67: 358–62.

    Article  CAS  Google Scholar 

  16. Tiemensma J, Kaptein AA, Pereira AM, Smit JW, Romijn JA, Biermasz NR. Coping strategies in patients after treatment for functioning or non-functioning pituitary adenomas. J Clin Endocrinol Metab 2011, 96: 964–71.

    Article  CAS  PubMed  Google Scholar 

  17. Matta MP, Couture E, Cazals L, Vezzosi D, Bennet A, Caron P. Impaired quality of life of patients with acromegaly: control of GH/IGF-I excess improves psychological subscale appearence. Eur J Endocrinol 2008, 158: 305–10.

    Article  CAS  PubMed  Google Scholar 

  18. Sardella M, Lombardi M, Rossi G, et al. Short and long term changes of quality of life in patients with acromegaly: Results from a prospective study. J Endocrinol Invest 2010, 33: 20–5.

    Article  CAS  PubMed  Google Scholar 

  19. van der Klaauw AA, Biermasz NR, Hoftijzer HC, Pereira AM, Romijn JA. Previous radiotherapy negatively influences quality of life during 4 years of follow-up in patients cured from acromegaly. Clin Endocrinol 2008, 69: 123–8.

    Article  Google Scholar 

  20. Engleman HM, Douglas NJ. Sleep. 4: Sleepiness, cognitive function, and quality of life in obstructive sleep apnoea/hypopnoea syndrome. Thorax 2004, 59: 618–22.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  21. Perks WH, Horrocks PM, Cooper RA, et al. Sleep apnoea in acromegaly. Br Med J 1980, 280: 894–7.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  22. Vannucci L, Luciani P, Gagliardi E, et al. Assessment of sleep apnea syndrome in treated acromegalic patients and correlation of its severity with clinical and laboratory parameters. J Endocrinol Invest 2013, 36: 237–42.

    CAS  PubMed  Google Scholar 

  23. Furmann K, Ezzat S. Psychological features of acromegaly. Psychother Psychosom 1998, 67: 147–53.

    Article  Google Scholar 

  24. Pantanetti P, Sonino N, Arnaldi G, Boscaro M. Self image and quality of life in acromegaly. Pituitary 2002, 5: 17–9.

    Article  CAS  PubMed  Google Scholar 

  25. Tiemensma J, Biermasz NR, van der Mast RC, et al. Increased psychopathology and maladaptive personality traits, but not cognitive functioning, in patients after long term cure of acromegaly. J Clin Endocrinol Metab 2010, 95: 392–402.

    Article  Google Scholar 

  26. Flitsch J, Spitzner S, Lüdecke DK. Emotional disorders in patients with different types of pituitary adenomas and factors affecting the diagnostic process. Exp Clin Endocrinol Diabetes 2000, 108: 480–5.

    Article  CAS  PubMed  Google Scholar 

  27. Sonino N, Ruini C, Navarrini C, et al. Psychosocial impairment in patients treated for pituitary disease: a controlled study. Clin Endocrinol (Oxf) 2007, 67: 719–26.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Cerrahpasa Tip Fakültesi, Ic Hastaliklari Anabilim Dali, Endokrinoloji-Metabolizma ve Diyabet Bilim Dali, University of Istanbul, 34303 Cerrahpasa, Istanbul, Turkey

    O. Celik &  P. Kadioglu

Authors
  1. O. Celik
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. P. Kadioglu
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to P. Kadioglu.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Celik, O., Kadioglu, P. Quality of life in female patients with acromegaly. J Endocrinol Invest 36, 412–416 (2013). https://doi.org/10.3275/8761

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.3275/8761

Key-words

Search

Navigation